Post-transplantation lymphoproliferative disorder in pediatric patient
Arq Bras Cardiol. 2006 Oct;87(4):e108-11.
doi: 10.1590/s0066-782x2006001700026.
[Article in
English,
Portuguese]
Affiliation
- 1 Instituto do Coração, Hospital das Clínicas, FM, USP, São Paulo, SP, Brazil. paulopego@cardiol.br
Abstract
Immunosuppressive therapy for transplanted patients exposes them to a high risk of developing posttransplantation lymphoproliferative disorders (PTLD). We report the case of a child undergoing heart transplantation at seven months of age who developed PTLD at nine years of age, diagnosed by resection of a pulmonary nodule.
MeSH terms
-
Cardiomyopathy, Dilated / surgery
-
Child
-
Heart Transplantation / adverse effects*
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Lymphoproliferative Disorders / diagnosis
-
Lymphoproliferative Disorders / drug therapy
-
Lymphoproliferative Disorders / etiology*
-
Male
-
Treatment Outcome